Roles of IFN-γ in tumor progression and regression: A review

In situ click chemistry generation of cyclooxygenase-2 inhibitors

Bhardwaj, A., Kaur, J., Wuest, M., & Wuest, F. (2017) · Nature Communications · doi:10.1038/s41467-016-0009-6 · Cited by 7,448 · see citing works

Macrophage plasticity, polarization, and function in health and disease

Shapouri‐Moghaddam, A., Mohammadian, S., Vazini, H., Taghadosi, M., Esmaeili, S., Mardani, F., Seifi, B., Mohammadi, A., Afshari, J. T., & Sahebkar, A. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.26429 · Cited by 4,930 · see citing works

Interferon-γ: an overview of signals, mechanisms and functions

Schroder, K., Hertzog, P. J., Ravasi, T., & Hume, D. A. (2004) · Journal of Leukocyte Biology · doi:10.1189/jlb.0603252 · Cited by 4,120 · see citing works

IFN-γ–related mRNA profile predicts clinical response to PD-1 blockade

Ayers, M., Lunceford, J., Nebozhyn, M., Murphy, E., Loboda, A., Kaufman, D. R., Albright, A., Cheng, J. D., Kang, S. P., Shankaran, V., et al. (2017) · Journal of Clinical Investigation · doi:10.1172/jci91190 · Cited by 3,788 · see citing works

A Novel Transcription Factor, T-bet, Directs Th1 Lineage Commitment

Szabo, S. J., Kim, S. T., Costa, G. L., Zhang, X., Fathman, C. G., & Glimcher, L. H. (2000) · Cell · doi:10.1016/s0092-8674(00)80702-3 · Cited by 3,589 · see citing works

Mechanisms of type-I- and type-II-interferon-mediated signalling

Platanias, L. C. (2005) · Nature reviews. Immunology · doi:10.1038/nri1604 · Cited by 3,480 · see citing works

CD8+ T cells regulate tumour ferroptosis during cancer immunotherapy

Wang, W., Green, M., Choi, J. E., Gijón, M., Kennedy, P. D., Johnson, J. K., Liao, P., Lang, X., Kryczek, I., Sell, A., et al. (2019) · Nature · doi:10.1038/s41586-019-1170-y · Cited by 2,880 · see citing works

Interferon Receptor Signaling Pathways Regulating PD-L1 and PD-L2 Expression

Garcia-Diaz, A., Shin, D. S., Moreno, B. H., Saco, J., Escuin-Ordinas, H., Rodriguez, G. A., Zaretsky, J. M., Sun, L., Hugo, W., Wang, X., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.04.031 · Cited by 1,942 · see citing works

De novo assembly of bacterial transcriptomes from RNA-seq data

Tjaden, B. C. (2015) · Genome biology · doi:10.1186/s13059-014-0572-2 · Cited by 1,695 · see citing works

Up-Regulation of PD-L1, IDO, and T _regs in the Melanoma Tumor Microenvironment Is Driven by CD8 ⁺ T Cells

Spranger, S., Spaapen, R. M., Zha, Y., Williams, J., Meng, Y., Ha, T. T., & Gajewski, T. F. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3006504 · Cited by 1,677 · see citing works

Regulation of Interferon‐γ During Innate and Adaptive Immune Responses

Schoenborn, J. R., & Wilson, C. B. (2007) · Advances in immunology · doi:10.1016/s0065-2776(07)96002-2 · Cited by 1,659 · see citing works

Th17: An Effector CD4 T Cell Lineage with Regulatory T Cell Ties

Weaver, C. T., Harrington, L. E., Mangan, P. R., Gavrieli, M., & Murphy, K. M. (2006) · Immunity · doi:10.1016/j.immuni.2006.06.002 · Cited by 1,422 · see citing works

IFNγ: signalling, epigenetics and roles in immunity, metabolism, disease and cancer immunotherapy

Ivashkiv, L. B. (2018) · Nature reviews. Immunology · doi:10.1038/s41577-018-0029-z · Cited by 1,374 · see citing works

Loss of IFN-γ pathway genes in tumor cells as a mechanism of resistance to anti-CTLA-4 therapy

Gao, J., Shi, L. Z., Zhao, H., Chen, J., Xiong, L., He, Q., Chen, T., Roszik, J., Bernatchez, C., Woodman, S. E., et al. (2016) · Cell · doi:10.1016/j.cell.2016.08.069 · Cited by 1,300 · cited 2× · see citing works

Correction: Corrigendum: MicroRNA122 is a key regulator of α-fetoprotein expression and influences the aggressiveness of hepatocellular carcinoma

Kojima, K., Takata, A., Vadnais, C., Otsuka, M., Yoshikawa, T., Akanuma, M., Kondo, Y., Kang, Y. J., Kishikawa, T., Kato, N., et al. (2012) · Nature Communications · doi:10.1038/ncomms2081 · Cited by 1,284 · see citing works

Effector and memory CD8+ T cell fate coupled by T-bet and eomesodermin

Intlekofer, A. M., Takemoto, N., Wherry, E. J., Longworth, S. A., Northrup, J. T., Palanivel, V., Mullen, A. C., Gasink, C. R., Kaech, S. M., Miller, J. D., et al. (2005) · Nature Immunology · doi:10.1038/ni1268 · Cited by 1,257 · see citing works

Interferon-Gamma at the Crossroads of Tumor Immune Surveillance or Evasion

Castro, F., Cardoso, A. P., Gonçalves, R. M., Serre, K., & Oliveira, M. J. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00847 · Cited by 1,224 · see citing works

Tumor Interferon Signaling Regulates a Multigenic Resistance Program to Immune Checkpoint Blockade

Benci, J. L., Xu, B., Qiu, Y., Wu, T. J., Dada, H., Twyman-Saint Victor, C., Cucolo, L., Lee, D. S. M., Pauken, K. E., Huang, A. C., et al. (2016) · Cell · doi:10.1016/j.cell.2016.11.022 · Cited by 1,216 · see citing works

Requirement for Stat4 in interleukin-12-mediated responses of natural killer and T cells

Thierfelder, W. E., van Deursen, J. M., Yamamoto, K., Tripp, R. A., Sarawar, S. R., Carson, R. T., Sangster, M. Y., Vignali, D. A. A., Doherty, P. C., Grosveld, G. C., et al. (1996) · Nature · doi:10.1038/382171a0 · Cited by 1,181 · see citing works

Distinct Effects of T-bet in T _H 1 Lineage Commitment and IFN-γ Production in CD4 and CD8 T Cells

Szabo, S. J., Sullivan, B. M., Stemmann, C., Satoskar, A. R., Sleckman, B. P., & Glimcher, L. H. (2002) · Science · doi:10.1126/science.1065543 · Cited by 1,172 · see citing works

Clinical impact of different classes of infiltrating T cytotoxic and helper cells (Th1, th2, treg, th17) in patients with colorectal cancer

Tosolini, M., Kirilovsky, A., Mlecnik, B., Fredriksen, T., Mauger, S., Bindea, G., Berger, A., Bruneval, P., Fridman, W.-H., Pagès, F., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-2907 · Cited by 1,146 · see citing works

Low-Dose Irradiation Programs Macrophage Differentiation to an iNOS+/M1 Phenotype that Orchestrates Effective T Cell Immunotherapy

Klug, F., Prakash, H., Huber, P. E., Seibel, T., Bender, N., Halama, N., Pfirschke, C., Voss, R. H., Timke, C., Umansky, L., et al. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.09.014 · Cited by 1,097 · see citing works

Control of Effector CD8 ⁺ T Cell Function by the Transcription Factor <i>Eomesodermin</i>

Pearce, E. L., Mullen, A. C., Martins, G. A., Krawczyk, C. M., Hutchins, A. S., Zediak, V. P., Banica, M., DiCioccio, C. B., Gross, D. A., Mao, C.-A., et al. (2003) · Science · doi:10.1126/science.1090148 · Cited by 1,014 · see citing works

Absence of Tumor Necrosis Factor Supports Alternative Activation of Macrophages in the Liver after Infection with Leishmania major

Hu, S., Marshall, C., Darby, J. M., Wei, W., Lyons, A. B., & Körner, H. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00001 · Cited by 982 · see citing works

Successful Anti-PD-1 Cancer Immunotherapy Requires T Cell-Dendritic Cell Crosstalk Involving the Cytokines IFN-γ and IL-12

Garris, C. S., Arlauckas, S. P., Kohler, R. H., Trefny, M. P., Garren, S., Piot, C., Engblom, C., Pfirschke, C., Siwicki, M., Gungabeesoon, J., et al. (2018) · Immunity · doi:10.1016/j.immuni.2018.09.024 · Cited by 966 · see citing works

Cross-regulation of Signaling Pathways by Interferon-γ: Implications for Immune Responses and Autoimmune Diseases

Hu, X., & Ivashkiv, L. B. (2009) · Immunity · doi:10.1016/j.immuni.2009.09.002 · Cited by 928 · see citing works

Antitumour actions of interferons: implications for cancer therapy

Parker, B. S., Rautela, J., & Hertzog, P. J. (2016) · Nature reviews. Cancer · doi:10.1038/nrc.2016.14 · Cited by 897 · see citing works

Identification of essential genes for cancer immunotherapy

Patel, S. J., Sanjana, N. E., Kishton, R. J., Eidizadeh, A., Vodnala, S. K., Cam, M., Gartner, J. J., Jia, L., Steinberg, S. M., Yamamoto, T. N., et al. (2017) · Nature · doi:10.1038/nature23477 · Cited by 870 · see citing works

Keeping It All Going—Complement Meets Metabolism

Kolev, M. V., & Kemper, C. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00001 · Cited by 819 · see citing works

Next generation of immune checkpoint therapy in cancer: new developments and challenges

Marin-Acevedo, J. A., Dholaria, B., Soyano, A. E., Knutson, K. L., Chumsri, S., & Lou, Y. (2018) · Journal of Hematology & Oncology · doi:10.1186/s13045-018-0582-8 · Cited by 802 · see citing works

Immune checkpoint inhibitors of PD-L1 as cancer therapeutics

Akinleye, A., & Rasool, Z. (2019) · Journal of Hematology & Oncology · doi:10.1186/s13045-019-0779-5 · Cited by 743 · see citing works

IFN-γ from lymphocytes induces PD-L1 expression and promotes progression of ovarian cancer

Abiko, K., Matsumura, N., Hamanishi, J., Horikawa, N., Murakami, R., Yamaguchi, K., Yoshioka, Y., Baba, T., Konishi, I., & Mandai, M. (2015) · British Journal of Cancer · doi:10.1038/bjc.2015.101 · Cited by 725 · see citing works

Interferon-Like Virus-Inhibitor Induced in Human Leukocytes by Phytohemagglutinin

Wheelock, Ε. F. (1965) · Science · doi:10.1126/science.149.3681.310 · Cited by 725 · see citing works

T-helper-1-cell cytokines drive cancer into senescence

Braumüller, H., Wieder, T., Brenner, E., Aßmann, S., Hahn, M., Alkhaled, M., Schilbach, K., Essmann, F., Kneilling, M., Griessinger, C., et al. (2013) · Nature · doi:10.1038/nature11824 · Cited by 720 · see citing works

Tumor-targeted T cells modified to secrete IL-12 eradicate systemic tumors without need for prior conditioning

Pegram, H. J., Lee, J., Hayman, E. G., Imperato, G. H., Tedder, T. F., Sadelain, M., & Brentjens, R. J. (2012) · Blood · doi:10.1182/blood-2011-12-400044 · Cited by 677 · see citing works

Correction: Corrigendum: The OncoPPi network of cancer-focused protein–protein interactions to inform biological insights and therapeutic strategies

Li, Z., Ivanov, A. A., Su, R., González-Pecchi, V., Qi, Q., Liu, S., Webber, P. J., McMillan, E. A., Rusnak, L. E., Pham, C., et al. (2017) · Nature Communications · doi:10.1038/ncomms15350 · Cited by 648 · see citing works

Interferon-γ Drives Treg Fragility to Promote Anti-tumor Immunity

Overacre-Delgoffe, A. E., Chikina, M., Dadey, R. E., Yano, H., Brunazzi, E. A., Shayan, G., Horne, W., Moskovitz, J. M., Kolls, J. K., Sander, C., et al. (2017) · Cell · doi:10.1016/j.cell.2017.05.005 · Cited by 627 · see citing works

Interferon γ and Its Important Roles in Promoting and Inhibiting Spontaneous and Therapeutic Cancer ImmunityPreprint

Alspach, E., Lussier, D. M., & Schreiber, R. D. (2018) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a028480 · Cited by 617 · see citing works

The Two Faces of Interferon-γ in Cancer

Zaidi, M. R., & Merlino, G. T. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-0482 · Cited by 594 · see citing works

Opposing Functions of Interferon Coordinate Adaptive and Innate Immune Responses to Cancer Immune Checkpoint Blockade

Benci, J. L., Johnson, L. R., Choa, R., Xu, Y., Qiu, J., Zhou, Z., Xu, B., Ye, D., Nathanson, K. L., June, C. H., et al. (2019) · Cell · doi:10.1016/j.cell.2019.07.019 · Cited by 541 · see citing works

Transcription factors T-bet and Runx3 cooperate to activate Ifng and silence Il4 in T helper type 1 cells

Djuretic, I. M., Levanon, D., Negreanu, V., Groner, Y., Rao, A., & Ansel, K. M. (2006) · Nature Immunology · doi:10.1038/ni1424 · Cited by 532 · see citing works

A high M1/M2 ratio of tumor-associated macrophages is associated with extended survival in ovarian cancer patients

Zhang, M., He, Y., Sun, X., Li, Q. Y., Wang, W., Zhao, A., & Di, W. J. (2014) · Journal of Ovarian Research · doi:10.1186/1757-2215-7-19 · Cited by 530 · see citing works

Characterization of the immunophenotypes and antigenomes of colorectal cancers reveals distinct tumor escape mechanisms and novel targets for immunotherapy

Angelova, M., Charoentong, P., Hackl, H., Fischer, M. L., Snajder, R., Krogsdam, A., Waldner, M. J., Bindea, G., Mlecnik, B., Galon, J., et al. (2015) · Genome biology · doi:10.1186/s13059-015-0620-6 · Cited by 521 · see citing works

Interferon-γ derived from cytotoxic lymphocytes directly enhances their motility and cytotoxicity

Bhat, P., Leggatt, G. R., Waterhouse, N. J., & Frazer, I. H. (2017) · Cell Death and Disease · doi:10.1038/cddis.2017.67 · Cited by 516 · see citing works

A Genomics-Based Classification of Human Lung Tumors

Thomas, R. K., Buettner, R., & Wolf, J. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3006802 · Cited by 508 · see citing works

Fates of CD8+ T cells in Tumor Microenvironment

Maimela, N. R., Liu, S., & Zhang, Y. (2019) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2018.11.004 · Cited by 459 · see citing works

IDO and regulatory T cells: a role for reverse signalling and non-canonical NF-κB activation

Puccetti, P., & Grohmann, U. (2007) · Nature reviews. Immunology · doi:10.1038/nri2163 · Cited by 457 · see citing works

Reprogramming mitochondrial metabolism in macrophages as an anti‐inflammatory signal

Mills, E. L., & O'Neill, L. A. J. (2015) · European Journal of Immunology · doi:10.1002/eji.201445427 · Cited by 454 · see citing works

Targeting the IDO1 pathway in cancer: from bench to bedside

Liu, M., Wang, X., Wang, L., Ma, X., Gong, Z., Zhang, S., & Li, Y. (2018) · Journal of Hematology & Oncology · doi:10.1186/s13045-018-0644-y · Cited by 449 · see citing works

The Interferon (IFN) Class of Cytokines and the IFN Regulatory Factor (IRF) Transcription Factor FamilyPreprint

Negishi, H., Taniguchi, T., & Yanai, H. (2017) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a028423 · Cited by 447 · see citing works

The M1 form of tumor-associated macrophages in non-small cell lung cancer is positively associated with survival time

Ma, J., Liu, L., Che, G., Yu, N., Dai, F., & You, Z. (2010) · BMC Cancer · doi:10.1186/1471-2407-10-112 · Cited by 439 · see citing works

CD4 CTL, a cytotoxic subset of CD4(+) T cells, their differentiation and function

Takeuchi, A., & Saito, T. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00194 · Cited by 431 · see citing works

Interferon γ Is Required for Activation-induced Death of T Lymphocytes

Refaeli, Y., Parijs, L. V., Alexander, S. I., & Abbas, A. K. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020666 · Cited by 415 · see citing works

Dual Faces of IFNγ in Cancer Progression: A Role of PD-L1 Induction in the Determination of Pro- and Antitumor Immunity

Mandai, M., Hamanishi, J., Abiko, K., Matsumura, N., Baba, T., & Konishi, I. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-0224 · Cited by 398 · see citing works

IL-21 in Synergy with IL-15 or IL-18 Enhances IFN-γ Production in Human NK and T Cells

Strengell, M., Matikainen, S., Sirén, J., Lehtonen, A., Foster, D., Julkunen, I., & Sareneva, T. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.11.5464 · Cited by 392 · see citing works

Lessons learned from the blockade of immune checkpoints in cancer immunotherapy

Li, X., Shao, C., Shi, Y., & Han, W. (2018) · Journal of Hematology & Oncology · doi:10.1186/s13045-018-0578-4 · Cited by 385 · see citing works

Interferon gamma in cancer immunotherapy

Ni, L., & Lu, J. (2018) · Cancer Medicine · doi:10.1002/cam4.1700 · Cited by 360 · see citing works

Treg Cells Promote the SREBP1-Dependent Metabolic Fitness of Tumor-Promoting Macrophages via Repression of CD8+ T Cell-Derived Interferon-γ

Liu, C., Chikina, M. D., Deshpande, R., Menk, A. V., Wang, T., Tabib, T., Brunazzi, E. A., Vignali, K. M., Sun, M., Stolz, D. B., et al. (2019) · Immunity · doi:10.1016/j.immuni.2019.06.017 · Cited by 347 · see citing works

Tumor-derived IFN triggers chronic pathway agonism and sensitivity to ADAR loss

Liu, H., Golji, J., Brodeur, L. K., Chung, F. S., Chen, J. T., deBeaumont, R. S., Bullock, C., Jones, M. D., Kerr, G., Li, L., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0302-5 · Cited by 346 · see citing works

T-bet and GATA3 orchestrate Th1 and Th2 differentiation through lineage-specific targeting of distal regulatory elements

Kanhere, A., Hertweck, A., Bhatia, U., Gökmen, M. R., Perucha, E., Jackson, I., Lord, G. M., & Jenner, R. G. (2012) · Nature Communications · doi:10.1038/ncomms2260 · Cited by 345 · see citing works

Changes in neuronal activation patterns in response to androgen deprivation therapy: a pilot study

Cherrier, M., Borghesani, P., Shelton, A., & Higano, C. (2010) · BMC Cancer · doi:10.1186/1471-2407-10-1 · Cited by 337 · see citing works

The Dark Side of IFN-γ: Its Role in Promoting Cancer Immunoevasion

Mojić, M., Takeda, K., & Hayakawa, Y. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms19010089 · Cited by 337 · see citing works

Interferon-γ acts directly on CD8+ T cells to increase their abundance during virus infection

Whitmire, J. K., Tan, J. T., & Whitton, J. L. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041463 · Cited by 332 · see citing works

PD-L1 expression, tumor mutational burden, and response to immunotherapy in patients with MET exon 14 altered lung cancers

Sabari, J. K., Leonardi, G. C., Shu, C. A., Umeton, R., Montecalvo, J., Ni, A., Chen, R., Dienstag, J., Mrad, C., Bergagnini, I., et al. (2018) · Annals of Oncology · doi:10.1093/annonc/mdy334 · Cited by 321 · see citing works

PD-L1 induced by IFN-γ from tumor-associated macrophages via the JAK/STAT3 and PI3K/AKT signaling pathways promoted progression of lung cancer

Zhang, X., Zeng, Y., Qu, Q., Zhu, J., Liu, Z., Ning, W., Zeng, H., Zhang, N., Du, W., Chen, C., et al. (2017) · International Journal of Clinical Oncology · doi:10.1007/s10147-017-1161-7 · Cited by 316 · see citing works

Interferon-γ-induced activation of JAK1 and JAK2 suppresses tumor cell susceptibility to NK cells through upregulation of PD-L1 expression

Bellucci, R., Martin, A., Bommarito, D., Wang, K., Hansen, S. H., Freeman, G. J., & Ritz, J. (2015) · OncoImmunology · doi:10.1080/2162402x.2015.1008824 · Cited by 307 · see citing works

Management of Malnutrition in Older Patients—Current Approaches, Evidence and Open Questions

Volkert, D., Beck, A. M., Cederholm, T., Cereda, E., Cruz-Jentoft, A. J., Goisser, S., de Groot, C. P. G. M., Grosshauser, F. J., Kiesswetter, E., Norman, K., et al. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8070974 · Cited by 306 · see citing works

TNFR1 Signaling and IFN-γ Signaling Determine whether T Cells Induce Tumor Dormancy or Promote Multistage Carcinogenesis

Müller-Hermelink, N., Braumüller, H., Pichler, B., Wieder, T., Mailhammer, R., Schaak, K., Ghoreschi, K., Yazdi, A., Haubner, R., Sander, C. A., et al. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.04.001 · Cited by 302 · see citing works

MS-Based Allotype-Specific Analysis of Polyclonal IgG-Fc N-Glycosylation

Sénard, T., Gargano, A., Falck, D., de Taeye, S. W., Rispens, T., Vidarsson, G., Wuhrer, M., Somsen, G. W., & Domínguez‐Vega, E. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.02049 · Cited by 297 · see citing works

Interferon-γ links ultraviolet radiation to melanomagenesis in mice

Zaidi, M. R., Davis, S., Noonan, F. P., Graff-Cherry, C., Hawley, T. S., Walker, R. L., Feigenbaum, L., Fuchs, E., Lyakh, L., Young, H. A., et al. (2011) · Nature · doi:10.1038/nature09666 · Cited by 293 · see citing works

Cutting Edge: IFN-γ Regulates the Induction and Expansion of IL-17-Producing CD4 T Cells during Mycobacterial Infection

Cruz, A., Khader, S. A., Torrado, E., Fraga, A. G., Pearl, J. E., Pedrosa, J., Cooper, A. M., & Castro, A. G. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.3.1416 · Cited by 287 · see citing works

Interferon gamma, an important marker of response to immune checkpoint blockade in non-small cell lung cancer and melanoma patients

Karachaliou, N., Gonzalez-Cao, M., Crespo, G., Drozdowskyj, A., Aldeguer, E., Gimenez-Capitan, A., Teixido, C., Molina-Vila, M. A., Viteri, S., De Los Llanos Gil, M., et al. (2018) · Therapeutic Advances in Medical Oncology · doi:10.1177/1758834017749748 · Cited by 285 · see citing works

Tumour ischaemia by interferon-γ resembles physiological blood vessel regression

Kammertoens, T., Friese, C., Arina, A., Idel, C., Briesemeister, D., Rothe, M., Ivanov, A., Szymborska, A., Patone, G., Kunz, S., et al. (2017) · Nature · doi:10.1038/nature22311 · Cited by 271 · see citing works

IFN-γ: A cytokine at the right time, is in the right place

Burke, J. D., & Young, H. A. (2019) · Seminars in Immunology · doi:10.1016/j.smim.2019.05.002 · Cited by 263 · see citing works

The IFN-γ/PD-L1 axis between T cells and tumor microenvironment: hints for glioma anti-PD-1/PD-L1 therapy

Qian, J., Wang, C., Wang, B., Yang, J., Wang, Y., Luo, F., Xu, J., Zhao, C. J., Liu, R., & Chu, Y. (2018) · Journal of Neuroinflammation · doi:10.1186/s12974-018-1330-2 · Cited by 262 · see citing works

Epidemiological trends of tracheal, bronchus, and lung cancer at the global, regional, and national levels: a population-based study

Deng, Y., Zhao, P., Zhou, L., Xiang, D., Hu, J., Liu, Y., Ruan, J., Ye, X., Zheng, Y., Yao, J., et al. (2020) · Journal of Hematology & Oncology · doi:10.1186/s13045-020-00915-0 · Cited by 260 · see citing works

Suppression of microRNA activity amplifies IFN-γ-induced macrophage activation and promotes anti-tumour immunity

Baer, C., Squadrito, M. L., Laoui, D., Thompson, D., Hansen, S. K., Kiialainen, A., Hoves, S., Ries, C. H., Ooi, C.-H., & De Palma, M. (2016) · Nature Cell Biology · doi:10.1038/ncb3371 · Cited by 259 · see citing works

The transcription factors T-bet and GATA-3 control alternative pathways of T-cell differentiation through a shared set of target genes

Jenner, R. G., Townsend, M. J., Jackson, I., Sun, K., Bouwman, R. D., Young, R. A., Glimcher, L. H., & Lord, G. M. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0909357106 · Cited by 252 · see citing works

Next-generation immuno-oncology agents: current momentum shifts in cancer immunotherapy

Pan, C.-X., Liu, H., Robins, E., Song, W., Liu, D., Li, Z., & Zheng, L. (2020) · Journal of Hematology & Oncology · doi:10.1186/s13045-020-00862-w · Cited by 245 · see citing works

Toll-Like Receptor Ligands and Interferon-γ Synergize for Induction of Antitumor M1 Macrophages

Müller, E., CHRISTOPOULOS, P. F., Halder, S., Lunde, A., Beraki, K., Speth, M. T., Øynebråten, I., & Corthay, A. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01383 · Cited by 241 · see citing works

Manipulation of the Innate Immune Response by Varicella Zoster Virus

Gerada, C., Campbell, T., Kennedy, J. J., Mcsharry, B. P., Steain, M., Slobedman, B., & Abendroth, A. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00001 · Cited by 234 · see citing works

Signal Transducer and Activator of Transcription 4 Is Required for the Transcription Factor T-bet to Promote T Helper 1 Cell-Fate Determination

Thieu, V. T., Yu, Q., Chang, H., Yeh, N., Nguyen, E., Sehra, S., & Kaplan, M. H. (2008) · Immunity · doi:10.1016/j.immuni.2008.08.017 · Cited by 231 · see citing works

Inhibition of MUC4 Expression Suppresses Pancreatic Tumor Cell Growth and Metastasis

Singh, A. P., Moniaux, N., Chauhan, S. C., Meza, J. L., & Batra, S. K. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2636 · Cited by 229 · see citing works

Tumor suppressor TET2 promotes cancer immunity and immunotherapy efficacy

Xu, Y., Lv, L., Liu, Y., Smith, M. D., Li, W., Tan, X. M., Cheng, M., Li, Z., Bovino, M., Aubé, J., et al. (2019) · Journal of Clinical Investigation · doi:10.1172/jci129317 · Cited by 227 · see citing works

NKp46 Receptor-Mediated Interferon-γ Production by Natural Killer Cells Increases Fibronectin 1 to Alter Tumor Architecture and Control Metastasis

Glasner, A., Levi, A., Enk, J., Isaacson, B., Viukov, S. V., Orlanski, S., Scope, A., Neuman, T., Enk, C. D., Hanna, J. H., et al. (2018) · Immunity · doi:10.1016/j.immuni.2017.12.007 · Cited by 221 · see citing works

IFN‐γ‐mediated inhibition of lung cancer correlates with PD‐L1 expression and is regulated by PI3K‐AKT signaling

Gao, Y., Yang, J., Cai, Y., Fu, S., Zhang, N., Fu, X., & Li, L. (2018) · International Journal of Cancer · doi:10.1002/ijc.31357 · Cited by 217 · see citing works

Role of the Akt pathway in mRNA translation of interferon-stimulated genes

Kaur, S., Sassano, A., Dolniak, B., Joshi, S., Majchrzak-Kita, B., Baker, D., Hay, N., Fish, E., & Platanias, L. (2008) · Proceedings of the National Academy of Sciences of the United States of America · doi:10.1073/pnas.0710907105 · Cited by 215 · see citing works

Interferon Gamma Messenger RNA Signature in Tumor Biopsies Predicts Outcomes in Patients with Non–Small Cell Lung Carcinoma or Urothelial Cancer Treated with Durvalumab

Higgs, B. W., Morehouse, C. A., Streicher, K. L., Brohawn, P. Z., Pilataxi, F., Gupta, A. K., & Ranade, K. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-3451 · Cited by 215 · see citing works

Tumor-intrinsic signaling pathways: key roles in the regulation of the immunosuppressive tumor microenvironment

Yang, L., Li, A., Lei, Q., & Zhang, Y. (2019) · Journal of Hematology &amp; Oncology · doi:10.1186/s13045-019-0804-8 · Cited by 215 · see citing works

Targeting the CBM complex causes Treg cells to prime tumours for immune checkpoint therapy

Di Pilato, M., Kim, E. Y., Cadilha, B. L., Prüßmann, J. N., Nasrallah, M. N., Seruggia, D., Usmani, S. M., Misale, S., Zappulli, V., Carrizosa, E., et al. (2019) · Nature · doi:10.1038/s41586-019-1215-2 · Cited by 210 · see citing works

The Interferon-Gamma Paradox in Cancer

Zaidi, M. R. (2018) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2018.0087 · Cited by 200 · see citing works

Differential Expression and Significance of PD-L1, IDO-1, and B7-H4 in Human Lung Cancer

Schalper, K. A., Carvajal‐Hausdorf, D., McLaughlin, J. F., Altan, M., Velcheti, V., Gaule, P., Sanmamed, M. F., Chen, L., Herbst, R. S., & Rimm, D. L. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-0150 · Cited by 199 · see citing works

Yin and yang interplay of IFN-γ in inflammation and autoimmune disease

Zhang, J. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31860 · Cited by 195 · see citing works

Long noncoding RNA GSTM3TV2 upregulates LAT2 and OLR1 by competitively sponging let-7 to promote gemcitabine resistance in pancreatic cancer

Xiong, G., Liu, C., Yang, G., Feng, M., Xu, J., Zhao, F., You, L., Zhou, L., Zheng, L., Hu, Y., et al. (2019) · Journal of Hematology & Oncology · doi:10.1186/s13045-019-0777-7 · Cited by 195 · see citing works

Dose-response of different dietary leucine levels on growth performance and amino acid metabolism in piglets differing for aminoadipate-semialdehyde synthase genotypes

Bertocchi, M., Bosi, P., Luise, D., Motta, V., Salvarani, C., Ribani, A., Bovo, S., Simongiovanni, A., Matsunaga, K., Takimoto, T., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-55006-z · Cited by 195 · see citing works

Human macrophages degrade tryptophan upon induction by interferon-gamma

Werner, E. R., Bitterlich, G., Fuchs, D., Hausen, A., Reibnegger, G. J., Szabó, G., Dierich, M. P., & Wächter, H. (1987) · Life Sciences · doi:10.1016/0024-3205(87)90149-4 · Cited by 189 · see citing works

Immune cell subset differentiation and tissue inflammation

Fang, P., Li, X., Dai, J., Cole, L. E., Camacho, J. A., Zhang, Y., Ji, Y. H., Wang, J., Yang, X., & Wang, H. (2018) · Journal of Hematology & Oncology · doi:10.1186/s13045-018-0637-x · Cited by 185 · see citing works

Galectin-3 captures interferon-gamma in the tumor matrix reducing chemokine gradient production and T-cell tumor infiltration

Gordón‐Alonso, M., Hirsch, T., Wildmann, C., & van der Bruggen, P. (2017) · Nature Communications · doi:10.1038/s41467-017-00925-6 · Cited by 184 · see citing works

Correction: Corrigendum: Ubiquitin ligase RNF20/40 facilitates spindle assembly and promotes breast carcinogenesis through stabilizing motor protein Eg5

Duan, Y., Huo, D., Gao, J., Wu, H., Ye, Z., Liu, Z., Zhang, K., Shan, L., Zhou, X., Wang, Y., et al. (2016) · Nature Communications · doi:10.1038/ncomms13462 · Cited by 183 · see citing works

Loss of Suppressor of Cytokine Signaling 1 in Helper T Cells Leads to Defective Th17 Differentiation by Enhancing Antagonistic Effects of IFN-γ on STAT3 and Smads

Tanaka, K., Ichiyama, K., Hashimoto, M., Yoshida, H., Takimoto, T., Takaesu, G., Torisu, T., Hanada, T., Yasukawa, H., Fukuyama, S., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.6.3746 · Cited by 182 · see citing works

Interferon-γ–triggered indoleamine 2,3-dioxygenase competence in human monocyte-derived dendritic cells induces regulatory activity in allogeneic T cells

Jürgens, B., Hainz, U., Fuchs, D., Felzmann, T., & Heitger, A. (2009) · Blood · doi:10.1182/blood-2008-12-195073 · Cited by 176 · see citing works

Tyrosine kinase inhibitor discontinuation in patients with chronic myeloid leukemia: a single-institution experience

Chamoun, K., Kantarjian, H. M., Atallah, R. P., et al. (2019) · Journal of Hematology & Oncology · doi:10.1186/s13045-018-0686-1 · Cited by 174 · see citing works

Interferon gamma inhibits CXCL8–CXCR2 axis mediated tumor-associated macrophages tumor trafficking and enhances anti-PD1 efficacy in pancreatic cancer

Zhang, M., Huang, L.-F., Ding, G., Huang, H., Cao, G., Sun, X. D., Lou, N., Wei, Q., Shen, T., Xu, X., et al. (2020) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2019-000308 · Cited by 171 · see citing works

IFNγ-activated dermal lymphatic vessels inhibit cytotoxic T cells in melanoma and inflamed skin

Lane, R. S., Femel, J., Breazeale, A. P., Loo, C. P., Thibault, G., Kaempf, A. J., Mori, M., Tsujikawa, T., Chang, Y. H., & Lund, A. W. (2018) · The Journal of Experimental Medicine · doi:10.1084/jem.20180654 · Cited by 166 · see citing works

Low-Dose IFNγ Induces Tumor Cell Stemness in Tumor Microenvironment of Non–Small Cell Lung Cancer

Song, M., Yü, P., Zhang, K., Yang, L., Li, F., Zhang, C., Cheng, S., Yue, D., Maimela, N. R., Qu, J., et al. (2019) · Cancer Research · doi:10.1158/0008-5472.can-19-0596 · Cited by 166 · see citing works

The regulatory network behind MHC class I expression

Jongsma, M. L. M., Guarda, G., & Spaapen, R. M. (2017) · Molecular Immunology · doi:10.1016/j.molimm.2017.12.005 · Cited by 162 · see citing works

Sterol Regulatory Element-binding Protein-1 (SREBP-1) Is Required to Regulate Glycogen Synthesis and Gluconeogenic Gene Expression in Mouse Liver

Ruiz, R., Jideonwo, V. N., Ahn, M., Surendran, S., Tagliabracci, V. S., Hou, Y., Gamble, A., Kerner, J., Irimia, J. M., Puchowicz, M. A., et al. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.541110 · Cited by 161 · see citing works

Extracellular Interactions of Alpha-Synuclein in Multiple System Atrophy

Valdinocci, D., Radford, R. A. W., Goulding, M., Hayashi, J., Chung, R. S., & Pountney, D. L. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19124129 · Cited by 161 · see citing works

IL-17A contributes to perioperative neurocognitive disorders through blood-brain barrier disruption in aged mice

Ni, P., Dong, H., Wang, Y., Zhou, Q., Xu, M., Qian, Y., & Sun, J. (2018) · Journal of Neuroinflammation · doi:10.1186/s12974-018-1374-3 · Cited by 160 · see citing works

Bystander IFN-γ activity promotes widespread and sustained cytokine signaling altering the tumor microenvironment

Thibaut, R., Bost, P., Milo, I., Cazaux, M., Lemaı̂tre, F., Garcia, Z., Amit, I., Bréart, B., Cornuot, C., Schwikowski, B., et al. (2020) · Nature Cancer · doi:10.1038/s43018-020-0038-2 · Cited by 160 · see citing works

IFN-γ mediates CD4+ T-cell loss and impairs secondary antitumor responses after successful initial immunotherapy

Berner, V. K., Liu, H., Zhou, Q., Alderson, K. L., Sun, K., Weiss, J. M., Back, T. C., Longo, D. L., Blazar, B. R., Wiltrout, R. H., et al. (2007) · Nature Medicine · doi:10.1038/nm1554 · Cited by 159 · see citing works

T reg cells limit IFN-γ production to control macrophage accrual and phenotype during skeletal muscle regeneration

Panduro, M., Benoist, C. O., & Mathis, D. J. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1800618115 · Cited by 157 · see citing works

IFN-γ is required for cytotoxic T cell-dependent cancer genome immunoediting

Takeda, K., NAKAYAMA, M., Hayakawa, Y., Kojima, Y., Ikeda, H., Imai, N., Ogasawara, K., Okumura, K., Thomas, D. M., & Smyth, M. J. (2017) · Nature Communications · doi:10.1038/ncomms14607 · Cited by 156 · see citing works

Interferon signaling is diminished with age and is associated with immune checkpoint blockade efficacy in triple-negative breast cancer

Sceneay, J., Goreczny, G. J., Wilson, K., Morrow, S., DeCristo, M. J., Ubellacker, J. M., Qin, Y., Laszewski, T., Stover, D. G., Barrera, V., et al. (2019) · Cancer Discovery · doi:10.1158/2159-8290.cd-18-1454 · Cited by 156 · see citing works

Natural killer T cell activation increases iNOS+CD206- M1 macrophage and controls the growth of solid tumor

Paul, S., Chhatar, S., Mishra, A., & Lal, G. (2019) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-019-0697-7 · Cited by 150 · see citing works

Long-distance modulation of bystander tumor cells by CD8+ T-cell-secreted IFN-γ

Hoekstra, M. E., Bornes, L., Dijkgraaf, F. E., Philips, D., Pardieck, I. N., Toebes, M., Thommen, D. S., van Rheenen, J., & Schumacher, T. N. (2020) · Nature Cancer · doi:10.1038/s43018-020-0036-4 · Cited by 143 · see citing works

Clonal Deletion of Tumor-Specific T Cells by Interferon-γ Confers Therapeutic Resistance to Combination Immune Checkpoint Blockade

Pai, C.-C. S., Huang, J. T., Lu, X., Simons, D. M., Park, C., Chang, A., Tamaki, W., Liu, E., Roybal, K. T., Seagal, J., et al. (2019) · Immunity · doi:10.1016/j.immuni.2019.01.006 · Cited by 141 · see citing works

Infiltration of diametrically polarized macrophages predicts overall survival of patients with gastric cancer after surgical resection

Zhang, H., Wang, X., Shen, Z., Xu, J., Qin, J., & Sun, Y. (2014) · Gastric Cancer · doi:10.1007/s10120-014-0422-7 · Cited by 139 · see citing works

Structure of the IFNγ receptor complex guides design of biased agonists

Mendoza, J. L., Escalante, N. K., Jude, K. M., Bellón, J. S., Su, L., Horton, T. M., Tsutsumi, N., Berardinelli, S. J., Haltiwanger, R. S., Piehler, J., et al. (2019) · Nature · doi:10.1038/s41586-019-0988-7 · Cited by 138 · see citing works

miR-153 suppresses IDO1 expression and enhances CAR T cell immunotherapy

Huang, Q., Xia, J., Wang, L., Wang, X., Ma, X., Deng, Q., Lu, Y., Kumar, M., Zhou, Z., Li, L., et al. (2018) · Journal of Hematology & Oncology · doi:10.1186/s13045-018-0600-x · Cited by 137 · see citing works

An intrinsic role of IL-33 in Treg cell–mediated tumor immunoevasion

Hatzioannou, A., Banos, A., Sakellaropoulos, T., Fedonidis, C., Vidali, M.-S., Köhne, M., Händler, K., Boon, L., Henriques, A. R., Koliaraki, V., et al. (2019) · Nature Immunology · doi:10.1038/s41590-019-0555-2 · Cited by 134 · see citing works

Interleukin-12 from CD103+ Batf3-Dependent Dendritic Cells Required for NK-Cell Suppression of Metastasis

Mittal, D., Vijayan, D., Putz, E. M., Aguilera, A. R., Markey, K. A., Straube, J., Kazakoff, S. H., Nutt, S. L., Takeda, K., Hill, G. R., et al. (2017) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-17-0341 · Cited by 130 · see citing works

Interferon-γ is an autocrine mediator for dendritic cell maturation

Pan, J., Zhang, M., Wang, J., Wang, Q., Xia, D., Sun, W., Zhang, L., Yu, H. C., Liu, Y.-J., & Cao, X. (2004) · Immunology Letters · doi:10.1016/j.imlet.2004.05.003 · Cited by 128 · see citing works

Impaired lipid biosynthesis hinders anti-tumor efficacy of intratumoral iNKT cells

Fu, S., He, K., Tian, C., Sun, H., Zhu, C., Bai, S., Liu, J., Wu, Q., Xie, D., Yue, T., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-14332-x · Cited by 125 · see citing works

Activation of the p70 S6 Kinase and Phosphorylation of the 4E-BP1 Repressor of mRNA Translation by Type I Interferons

Lekmine, F., Shahab Uddin, M. S., Sassano, A., Parmar, S., Brachmann, S. M., Majchrzak, B., Sonenberg, N., Hay, N., Fish, E. N., & Platanias, L. C. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301364200 · Cited by 123 · see citing works

Interferon-γ Signaling in Melanocytes and Melanoma Cells Regulates Expression of CTLA-4

Mo, X., Zhang, H., Preston, S., Martin, K. A., Zhou, B., Vadalia, N., Gamero, A. M., Soboloff, J., Tempera, I., & Zaidi, M. R. (2017) · Cancer Research · doi:10.1158/0008-5472.can-17-1615 · Cited by 118 · see citing works

Cancer biomarkers for targeted therapy

Liu, D. (2019) · Biomarker Research · doi:10.1186/s40364-019-0178-7 · Cited by 117 · see citing works

Cutting Edge: The Th1 Response Inhibits the Generation of Peripheral Regulatory T Cells

Caretto, D., Katzman, S. D., Villarino, A. V., Gallo, E., & Abbas, A. K. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0903412 · Cited by 115 · see citing works

MLMDA: a machine learning approach to predict and validate MicroRNA–disease associations by integrating of heterogenous information sources

Zheng, K., You, Z., Wang, L., Zhou, Y. Z., Li, L., & Li, Z. (2019) · Journal of Translational Medicine · doi:10.1186/s12967-019-2009-x · Cited by 113 · see citing works

Disruption of SIRT7 Increases the Efficacy of Checkpoint Inhibitor via MEF2D Regulation of Programmed Cell Death 1 Ligand 1 in Hepatocellular Carcinoma Cells

Xiang, J., Zhang, N., Sun, H., Su, L., Zhang, C., Xu, H., Feng, J., Wang, M., Chen, J., Liu, L., et al. (2019) · Gastroenterology · doi:10.1053/j.gastro.2019.10.025 · Cited by 113 · see citing works

Interdependent IL-7 and IFN-γ signalling in T-cell controls tumour eradication by combined α-CTLA-4+α-PD-1 therapy

Shi, L. Z., Fu, T., Guan, B., Chen, J., Blando, J. M., Allison, J. P., Xiong, L., Subudhi, S. K., Gao, J., & Sharma, P. (2016) · Nature Communications · doi:10.1038/ncomms12335 · Cited by 111 · see citing works

Loss of ELF5–FBXW7 stabilizes IFNGR1 to promote the growth and metastasis of triple-negative breast cancer through interferon-γ signalling

Singh, S., Kumar, S., Srivastava, R. K., Nandi, A., Thacker, G., Murali, H., Kim, S., Baldeon, M. A., Tobias, J. W., Blanco, M. A., et al. (2020) · Nature Cell Biology · doi:10.1038/s41556-020-0495-y · Cited by 107 · see citing works

Regulation of IFN-γ Signaling Is Essential for the Cytotoxic Activity of CD8+ T Cells

Tau, G. Z., Cowan, S., Weisburg, J. H., et al. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.10.5574 · Cited by 106 · see citing works

B cells expressing IFN‐γ suppress Treg‐cell differentiation and promote autoimmune experimental arthritis

Olalekan, S. A., Cao, Y., Hamel, K. M., & Finnegan, A. (2015) · European Journal of Immunology · doi:10.1002/eji.201445036 · Cited by 101 · see citing works

Induction of Indoleamine 2,3-Dioxygenase by Interferon-γ in Human Islets

Sarkar, S. A., Wong, R., Hackl, S. I., Moua, O., Gill, R. G., Wiseman, A. C., Davidson, H. W., & Hutton, J. C. (2006) · Diabetes · doi:10.2337/db06-0617 · Cited by 101 · see citing works

BRE modulates granulosa cell death to affect ovarian follicle development and atresia in the mouse

Yeung, C. K., Wang, G., Yao, Y., et al. (2017) · Cell Death and Disease · doi:10.1038/cddis.2017.91 · Cited by 101 · see citing works

Interferon-gamma engages the p70 S6 kinase to regulate phosphorylation of the 40S S6 ribosomal protein.

Lekmine, F., Sassano, A., Uddin, S., Smith, J. G., Majchrzak, B., Brachmann, S., Hay, N., Fish, E., & Platanias, L. (2004) · Experimental Cell Research · doi:10.1016/j.yexcr.2003.12.021 · Cited by 99 · see citing works

Prognostic and predictive role of tumour-associated macrophages in HER2 positive breast cancer

Honkanen, T. J., Tikkanen, A., Karihtala, P., Mäkinen, M. J., Väyrynen, J. P., & Koivunen, J. P. (2019) · Scientific Reports · doi:10.1038/s41598-019-47375-2 · Cited by 98 · see citing works

IFN-γ-Induced MHC Class II Expression: Transactivation of Class II Transactivator Promoter IV by IFN Regulatory Factor-1 is Regulated by Protein Kinase C-α

Giroux, M., Schmidt, M., & Descoteaux, A. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.8.4187 · Cited by 95 · see citing works

IFNγ-Induced IFIT5 Promotes Epithelial-to-Mesenchymal Transition in Prostate Cancer via miRNA Processing

Lo, U., Pong, R.-C., Yang, D., et al. (2018) · Cancer Research · doi:10.1158/0008-5472.can-18-2207 · Cited by 93 · see citing works

Impaired uterine artery flow associated with the presence of ovarian endometrioma: preliminary results of a prospective study

Porpora, M. G., Tomao, F., Manganaro, L., Yazdanian, D., Fuggetta, E., Piccioni, M. G., Panici, P. B., & Benagiano, G. (2014) · Journal of Ovarian Research · doi:10.1186/1757-2215-7-1 · Cited by 92 · see citing works

Gilteritinib: a novel FLT3 inhibitor for acute myeloid leukemia

Zhao, J.-J., Song, Y., & Liu, D. (2019) · Biomarker Research · doi:10.1186/s40364-019-0170-2 · Cited by 86 · see citing works

Expression of Indoleamine 2,3-Dioxygenase Induced by IFN-γ and TNF-α as Potential Biomarker of Prostate Cancer Progression

Banzola, I., Mengus, C., Wyler, S. F., Hudolin, T., Manzella, G., Chiarugi, A., Boldorini, R. L., Sais, G., Schmidli, T. S., Chiffi, G., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01051 · Cited by 80 · see citing works

Sustained low-level expression of interferon-γ promotes tumor development: potential insights in tumor prevention and tumor immunotherapy

He, Y., Wang, X., Zhang, G., Chen, H., Zhang, H., & Feng, Z. (2005) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-004-0654-1 · Cited by 75 · see citing works

Tumor rejection by local interferon gamma induction in established tumors is associated with blood vessel destruction and necrosis

Briesemeister, D., Sommermeyer, D., Loddenkemper, C., Loew, R., Uckert, W., Blankenstein, T. J. F., & Kammertoens, T. (2010) · International Journal of Cancer · doi:10.1002/ijc.25350 · Cited by 69 · see citing works

Responsiveness of Stromal Fibroblasts to IFN-γ Blocks Tumor Growth via Angiostasis

Yu, L., Yang, W. C., Qin, C., Zhang, L., Deng, J., Liu, S., & Qin, Z. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901073 · Cited by 69 · see citing works

IκBζ augments IL-12- and IL-18-mediated IFN-γ production in human NK cells.

Kannan, Y., Yu, J.-H., Raices, R., Seshadri, S., Wei, M., Caligiuri, M., & Wewers, M. (2011) · Blood · doi:10.1182/blood-2010-07-294702 · Cited by 67 · see citing works

Increased sensitivity of Treg cells from patients with PBC to low dose IL-12 drives their differentiation into IFN-γ secreting cells

Liaskou, E., Patel, S. R., Webb, G. J., Dimakou, D. B., Akiror, S., Krishna, M., Mells, G. F., Jones, D. E., Bowman, S., Barone, F., et al. (2018) · Journal of Autoimmunity · doi:10.1016/j.jaut.2018.07.020 · Cited by 67 · see citing works

Th1 cytokine-based immunotherapy for cancer

Xu, H. (2014) · Hepatobiliary & pancreatic diseases international · doi:10.1016/s1499-3872(14)60305-2 · Cited by 66 · see citing works

Mesenchymal Stromal Cells Can Regulate the Immune Response in the Tumor Microenvironment

Poggi, A. D., & Giuliani, M. (2016) · Vaccines · doi:10.3390/vaccines4040041 · Cited by 62 · see citing works

Interferon regulatory factor 1 priming of tumour-derived exosomes enhances the antitumour immune response

Yang, M., Du, Q., Varley, P. R., et al. (2017) · British Journal of Cancer · doi:10.1038/bjc.2017.389 · Cited by 62 · see citing works

Indoleamine-2,3-Dioxygenase in Thyroid Cancer Cells Suppresses Natural Killer Cell Function by Inhibiting NKG2D and NKp46 Expression via STAT Signaling Pathways

Park, A., Yang, Y., Lee, Y., Kim, M. S., Park, Y., Jung, H., Kim, T., Lee, H. G., Choi, I., & Yoon, S. R. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8060842 · Cited by 62 · see citing works

Cutting Edge: Committed Th1 CD4+ T Cell Differentiation Blocks Pregnancy-Induced Foxp3 Expression with Antigen-Specific Fetal Loss

Xin, L., Ertelt, J. M., Rowe, J. H., et al. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1302678 · Cited by 60 · see citing works

IFN-γ selectively exerts pro-apoptotic effects on tumor-initiating label-retaining colon cancer cells

Ni, C., Wu, P., Zhu, X., et al. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.04.029 · Cited by 57 · see citing works

TIM-3/Gal-9 interaction induces IFNγ-dependent IDO1 expression in acute myeloid leukemia blast cells

Folgiero, V., Cifaldi, L., Pira, G. L., et al. (2015) · Journal of Hematology & Oncology · doi:10.1186/s13045-015-0134-4 · Cited by 57 · see citing works

Interferon-γ-dependent immune responses contribute to the pathogenesis of sclerosing cholangitis in mice

Ravichandran, G., Neumann, K., Berkhout, L. K., Weidemann, S. A., Langeneckert, A. E., Schwinge, D., Poch, T., Huber, S., Schiller, B., Hess, L. U., et al. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2019.05.023 · Cited by 56 · see citing works

Enhancement of metastatic potential by gamma-interferon.

Kelly, S., Gschmeissner, S., East, N., et al. (1991) · PubMed · Cited by 53 · see citing works

IFN-γ-induced expression of MUC4 in pancreatic cancer cells is mediated by STAT-1 upregulation: a novel mechanism for IFN-γ response

Andrianifahanana, M., Singh, A. P., Némos, C., Ponnusamy, M. P., Moniaux, N., Mehta, P. P., Varshney, G. C., & Batra, S. K. (2007) · Oncogene · doi:10.1038/sj.onc.1210532 · Cited by 52 · see citing works

Interferon-γ Limits Diabetogenic CD8+ T-Cell Effector Responses in Type 1 Diabetes

Driver, J. P., Racine, J. J., Cheng, Y., et al. (2016) · Diabetes · doi:10.2337/db16-0846 · Cited by 44 · see citing works

Non-myeloablative allogeneic hematopoietic cell transplantation following fludarabine plus 2 Gy TBI or ATG plus 8 Gy TLI: a phase II randomized study from the Belgian Hematological Society

Baron, F., Zachée, P., Maertens, J. A., Kerre, T. C. C., Ory, A., Seidel, L., Graux, C., Lewalle, P., van Gelder, M., Theunissen, K., et al. (2015) · Journal of Hematology & Oncology · doi:10.1186/s13045-014-0098-9 · Cited by 43 · see citing works

Confidence and self-attribution bias in an artificial stock market

Bertella, M. A., Pires, F. R., Rêgo, H. H. A., Silva, J. N., Vodenska, I., & Stanley, E. (2017) · PLoS ONE · doi:10.1371/journal.pone.0172258 · Cited by 41 · see citing works

Interferon gamma induces inflammatory responses through the interaction of CEACAM1 and PI3K in airway epithelial cells

Zhu, Y., Song, D., Song, Y., & Wang, X. (2019) · Journal of Translational Medicine · doi:10.1186/s12967-019-1894-3 · Cited by 40 · see citing works

Tumor-associated and immunochemotherapy-dependent long-term alterations of the peripheral blood NK cell compartment in DLBCL patients

Cox, M. C., Battella, S., Scaleia, R. L., Pelliccia, S., Napoli, A. D., Porzia, A., Cecere, F., Alma, E., Zingoni, A., Mainiero, F., et al. (2015) · OncoImmunology · doi:10.4161/2162402x.2014.990773 · Cited by 38 · see citing works

Antigen-Specific Naive CD8+ T Cells Produce a Single Pulse of IFN-γ In Vivo within Hours of Infection, but without Antiviral Effect

Hosking, M., Flynn, C. T., & Whitton, J. L. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1400348 · Cited by 38 · see citing works

IFN‐γ withdrawal after immunotherapy potentiates B16 melanoma invasion and metastasis by intensifying tumor integrin αvβ3 signaling

Gong, W., Zhang, G., Liu, Y., et al. (2008) · International Journal of Cancer · doi:10.1002/ijc.23553 · Cited by 35 · see citing works

Induction of metastatic cancer stem cells from the NK/LAK-resistant floating, but not adherent, subset of the UP-LN1 carcinoma cell line by IFN-γ

Chen, H., Chou, A. S., Liu, Y., et al. (2011) · Laboratory Investigation · doi:10.1038/labinvest.2011.91 · Cited by 33 · see citing works

Interferon-γ and Smac mimetics synergize to induce apoptosis of lung cancer cells in a TNFα-independent manner

Hao, Q., & Tang, H. L. (2018) · Cancer Cell International · doi:10.1186/s12935-018-0579-y · Cited by 32 · see citing works

Interferon-induced IFIT5 promotes epithelial-to-mesenchymal transition leading to renal cancer invasion.

Lo, U., Bao, J., Cen, J., Yeh, H., Luo, J., Tan, W., & Hsieh, J. (2019) · Europe PMC (PubMed Central) · Cited by 30 · see citing works

RIPK3: Beyond Necroptosis

Evans, A. S., & Coyne, C. B. (2019) · Immunity · doi:10.1016/j.immuni.2018.12.031 · Cited by 25 · see citing works

Activation of IRF3 contributes to IFN-γ and ISG54 expression during the immune responses to B16F10 tumor growth

Guinn, Z. P., Brown, D. M., & Petro, T. M. (2017) · International Immunopharmacology · doi:10.1016/j.intimp.2017.06.016 · Cited by 24 · see citing works

Molecular modeling of the effects of glycosylation on the structure and dynamics of human interferon-gamma

Lilkova, E., Petkov, P., Ilieva, N., Krachmarova, E., Nacheva, G. A., & Litov, L. (2019) · Journal of Molecular Modeling · doi:10.1007/s00894-019-4013-8 · Cited by 23 · see citing works

Inducible IFN-γ Expression for MHC-I Upregulation in Devil Facial Tumor Cells

Ong, C. E. B., Lyons, A. B., Woods, G. M., & Flies, A. S. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2018.03117 · Cited by 22 · see citing works

mTOR signaling promotes a robust and continuous production of IFN‐γ by human memory CD8⁺ T cells and their proliferation

Setoguchi, R., Matsui, Y., & Mouri, K. (2015) · European Journal of Immunology · doi:10.1002/eji.201445086 · Cited by 21 · see citing works

Accelerated tumour metastasis due to interferon‐γ receptor‐mediated dissociation of perivascular cells from blood vessels

Ni, C., Ma, P., Qu, L.-W., Wu, F., Hao, J., Wang, R., Lu, Y., Yang, W. C., Erben, U., & Qin, Z. (2017) · The Journal of Pathology · doi:10.1002/path.4907 · Cited by 20 · see citing works

Discovery of KIRREL as a biomarker for prognostic stratification of patients with thin melanoma

Lundgren, S., Fagerström-Vahman, H., Zhang, C., et al. (2019) · Biomarker Research · doi:10.1186/s40364-018-0153-8 · Cited by 19 · see citing works

Inhibition of Major Histocompatibility Complex Class II-Dependent Antigen Presentation by Neutralization of Gamma Interferon Leads to Breakdown of Resistance against Measles Virus-Induced Encephalitis

Weidinger, G., Henning, G., ter Meulen, V., et al. (2001) · Journal of Virology · doi:10.1128/jvi.75.7.3059-3065.2001 · Cited by 18 · see citing works

Keeping the Death Protein in Check

Wang, L., & Wu, H. (2019) · Immunity · doi:10.1016/j.immuni.2019.06.011 · Cited by 18 · see citing works

Cytokine Stimulation of MUC4 Expression in Human Female Reproductive Tissue Carcinoma Cell Lines and Endometrial Cancer

Chapela, P., Broaddus, R. R., Hawkins, S. M., et al. (2015) · Journal of Cellular Biochemistry · doi:10.1002/jcb.25213 · Cited by 15 · see citing works

IFN-γ Expressed by T Cells Regulates the Persistence of Antigen Presentation by Limiting the Survival of Dendritic Cells

Russell, M. S., Dudani, R., Krishnan, L., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901274 · Cited by 14 · see citing works

Splenic Leukocytes Get the Nerves up for Myelopoiesis

Hu, Z., & Zeng, W. (2018) · Immunity · doi:10.1016/j.immuni.2018.06.014 · Cited by 14 · see citing works

Detection of Blood Lipids, Homocysteine and Endothelin in Patients with Hypothyroidism and Subclinical Hypothyroidism and Its Clinical Significance

Hongyan, L. (2019) · American Journal of Clinical and Experimental Medicine · doi:10.11648/j.ajcem.20190701.14 · Cited by 13 · see citing works

Defective Interferon Gamma Production by Tumor-Specific CD8+ T Cells Is Associated With 5′Methylcytosine-Guanine Hypermethylation of Interferon Gamma Promoter

Hamid, M. A., Yao, X., Waugh, C., Rosendo-Machado, S., Li, C., Rostron, T., Frankland, J., Peng, Y., & Dong, T. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00310 · Cited by 13 · see citing works

IFN-γ fails to overcome inhibition of selected macrophage activation events in response to pathogenic mycobacteria

Thirunavukkarasu, S., Plain, K. M., Purdie, A. C., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0176400 · Cited by 11 · see citing works

Inhibitory mechanism of 17β-aminoestrogens in the formation of Aβ aggregates

Noriega, L., Díaz, A., Limón, I. D., et al. (2019) · Journal of Molecular Modeling · doi:10.1007/s00894-019-4128-y · Cited by 2 · see citing works

Immune Checkpoint Inhibitors in Cancer Therapy

Shiravand, Y., Khodadadi, F., Kashani, S. M. A., Hosseini-Fard, S. R., Hosseini, S., Sadeghirad, H., Ladwa, R., O’Byrne, K., & Kulasinghe, A. (2022) · Current Oncology · doi:10.3390/curroncol29050247 · Cited by 1,353 · see citing works

Combination strategies to maximize the benefits of cancer immunotherapy

Zhu, S., Zhang, T., Zheng, L., Liu, H., Song, W., Liu, D., Li, Z., & Pan, C.-X. (2021) · Journal of Hematology &amp; Oncology · doi:10.1186/s13045-021-01164-5 · Cited by 654 · see citing works

Research progress on interferon and cellular senescence

Wang, D., Chen, K., Wang, Z., Wu, H., & Li, Y. (2024) · The FASEB Journal · doi:10.1096/fj.202400808rr · Cited by 23 · see citing works

Sunitinib lipid nanoparticles remodel tumor vasculature to synergize with two-stage radiotherapy for enhanced radiosensitivity in breast Cancer

Li, P., Dong, Z., Jiang, Q., Yu, C., Liu, Y., Yuan, R., Qiu, Y., Meng, T., Hu, F., & Yuan, H. (2026) · Journal of Controlled Release · doi:10.1016/j.jconrel.2025.114406 · Cited by 6 · see citing works

The First Tianjin, China Forum on Tumor Microenvironment

Keller, E. T., & Li, L.-Y. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-2930 · Cited by 6 · see citing works

Role of the tumor microenvironment in tumor progression and the clinical applications (Review)

YUAN, Y., JIANG, Y.-C., SUN, C.-K., & CHEN, Q.-M. (2016) · Oncology Reports · doi:10.3892/or.2016.4660 · Cited by 320 · see citing works

PRSS2 remodels the tumor microenvironment via repression of Tsp1 to stimulate tumor growth and progression

Sui, L., Wang, S., Ganguly, D., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-35649-9 · Cited by 24 · see citing works

Tumor microenvironment components: Allies of cancer progression

Franco, P. I. R., Rodrigues, A. P., de Menezes, L. B., & Miguel, M. P. (2019) · Pathology - Research and Practice · doi:10.1016/j.prp.2019.152729 · Cited by 243 · see citing works

Data from The First Tianjin, China Forum on Tumor Microenvironment

Keller, E. T., & Li, L. (2023) · doi:10.1158/0008-5472.c.6502869.v1